Diagnostic Intracorporeal Papaverine and Erectile Dysfunction
- 1 March 1987
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 59 (3), 264-266
- https://doi.org/10.1111/j.1464-410x.1987.tb04620.x
Abstract
Intracorporeal papaverine has been used as an out-patient procedure to assess the erectile dysfunction of 129 men. The technique is a valuable diagnostic aid and has few side effects. Prolonged tumescence occurred in four patients, two of whom required treatment with intracorporeal metaraminol.This publication has 9 references indexed in Scilit:
- Diagnostic Tests for Impotence: A Comparison of Papaverine Injection with the Penile-Brachial Index and Nocturnal Penile Tumescence MonitoringJournal of Urology, 1986
- Intracavernous Drug-Induced Erections in the Management of Male Erectile Dysfunction: Experience with 100 PatientsJournal of Urology, 1986
- Is Intracavernous Injection of Papaverine a Reliable Screening Test for Vascular Impotence?Journal of Urology, 1986
- Pilot experiments on the actions of drugs injected into the human corpus cavernosum penisBritish Journal of Pharmacology, 1986
- Surgery for Peyronie's Disease: A Review of 200 PatientsBritish Journal of Urology, 1985
- NEW TREATMENT FOR PRIAPISMThe Lancet, 1984
- Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile ImpotenceThe British Journal of Psychiatry, 1983
- INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILUREThe Lancet, 1982
- Sleep-related penile tumescence as a function of ageAmerican Journal of Psychiatry, 1975